These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32387238)

  • 1. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
    Amiral J; Vissac AM; Seghatchian J
    Transfus Apher Sci; 2020 Jun; 59(3):102804. PubMed ID: 32387238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from dermatology about inflammatory responses in Covid-19.
    Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
    Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M
    Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
    Buszko M; Park JH; Verthelyi D; Sen R; Young HA; Rosenberg AS
    Nat Immunol; 2020 Oct; 21(10):1146-1151. PubMed ID: 32855555
    [No Abstract]   [Full Text] [Related]  

  • 7. Age-Related Differences in Immunological Responses to SARS-CoV-2.
    Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
    J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).
    Parra-Izquierdo I; Aslan JE
    Semin Thromb Hemost; 2020 Oct; 46(7):826-830. PubMed ID: 32882716
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
    Rossi GA; Sacco O; Mancino E; Cristiani L; Midulla F
    Infection; 2020 Oct; 48(5):665-669. PubMed ID: 32737833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The RAAS and SARS-CoV-2: A riddle to solve].
    Choi M; Aiello EA; Ennis IL; Villa-Abrille MC
    Hipertens Riesgo Vasc; 2020; 37(4):169-175. PubMed ID: 32527699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
    Mozzini C; Girelli D
    Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
    [No Abstract]   [Full Text] [Related]  

  • 15. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
    Zemlin AE; Wiese OJ
    Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
    Beeraka NM; Sadhu SP; Madhunapantula SV; Rao Pragada R; Svistunov AA; Nikolenko VN; Mikhaleva LM; Aliev G
    Front Immunol; 2020; 11():552925. PubMed ID: 33072093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
    Ju B; Zhang Q; Ge J; Wang R; Sun J; Ge X; Yu J; Shan S; Zhou B; Song S; Tang X; Yu J; Lan J; Yuan J; Wang H; Zhao J; Zhang S; Wang Y; Shi X; Liu L; Zhao J; Wang X; Zhang Z; Zhang L
    Nature; 2020 Aug; 584(7819):115-119. PubMed ID: 32454513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
    Sawalha AH; Zhao M; Coit P; Lu Q
    Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
    Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
    Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.